Vertex Pharmaceuticals (VRTX) announced data from a Phase 4 study of JOURNAVX, a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults, that ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

Smart city initiatives are generating vast amounts of data from sensors, cameras, mobile devices, and digital service ...

Read more about How AI and blockchain are reinventing multimodal logistics for disruption-prone world on Devdiscourse ...

By Hugo Francisco de Souza A massive new multimodal AI system trained on tens of millions of medical images could help unify fragmented radiology tools and assist doctors in interpreting scans and ...

By Dr. Liji Thomas, MD By merging voice instability, gait asymmetry, and tremor-driven handwriting changes into a single explainable AI framework, researchers show how digital biomarkers can move ...

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients ...